These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
2851 |
|
||||||||||||
(State or other jurisdiction of
incorporation or organization) |
(Primary Standard Industrial
Classification Code Number) |
(I.R.S. Employer
Identification No.) |
|
|
|
||||||||||||
(Title of class) | (Trading symbol) | (Exchange on which registered) |
Three Months Ended
March 31, |
||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Net sales | $ |
|
$ |
|
||||||||||||||||||||||
Cost of goods sold |
|
|
||||||||||||||||||||||||
Selling, general and administrative expenses |
|
|
||||||||||||||||||||||||
Other operating charges |
|
|
||||||||||||||||||||||||
Research and development expenses |
|
|
||||||||||||||||||||||||
Amortization of acquired intangibles |
|
|
||||||||||||||||||||||||
Income from operations |
|
|
||||||||||||||||||||||||
Interest expense, net |
|
|
||||||||||||||||||||||||
Other expense, net |
|
|
||||||||||||||||||||||||
Income before income taxes |
|
|
||||||||||||||||||||||||
Provision for income taxes |
|
|
||||||||||||||||||||||||
Net income |
|
|
||||||||||||||||||||||||
Less: Net loss attributable to noncontrolling interests |
(
|
|
||||||||||||||||||||||||
Net income attributable to common shareholders | $ |
|
$ |
|
||||||||||||||||||||||
Basic net income per share | $ |
|
$ |
|
||||||||||||||||||||||
Diluted net income per share | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Net income | $ |
|
$ |
|
||||||||||||||||||||||
Other comprehensive (loss) income, before tax: | ||||||||||||||||||||||||||
Foreign currency translation adjustments |
(
|
|
||||||||||||||||||||||||
Unrealized loss on derivatives |
|
(
|
||||||||||||||||||||||||
Unrealized gain on pension and other benefit plan obligations |
|
|
||||||||||||||||||||||||
Other comprehensive (loss) income, before tax |
(
|
|
||||||||||||||||||||||||
Income tax provision related to items of other comprehensive (loss) income |
|
|
||||||||||||||||||||||||
Other comprehensive (loss) income, net of tax |
(
|
|
||||||||||||||||||||||||
Comprehensive (loss) income |
(
|
|
||||||||||||||||||||||||
Less: Comprehensive loss attributable to noncontrolling interests |
(
|
(
|
||||||||||||||||||||||||
Comprehensive (loss) income attributable to common shareholders | $ |
(
|
$ |
|
March 31, 2024 | December 31, 2023 | |||||||||||||
Assets | ||||||||||||||
Current assets: | ||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
||||||||||
Restricted cash |
|
|
||||||||||||
Accounts and notes receivable, net |
|
|
||||||||||||
Inventories |
|
|
||||||||||||
Prepaid expenses and other current assets |
|
|
||||||||||||
Total current assets |
|
|
||||||||||||
Property, plant and equipment, net |
|
|
||||||||||||
Goodwill |
|
|
||||||||||||
Identifiable intangibles, net |
|
|
||||||||||||
Other assets |
|
|
||||||||||||
Total assets | $ |
|
$ |
|
||||||||||
Liabilities, Shareholders’ Equity | ||||||||||||||
Current liabilities: | ||||||||||||||
Accounts payable | $ |
|
$ |
|
||||||||||
Current portion of borrowings |
|
|
||||||||||||
Other accrued liabilities |
|
|
||||||||||||
Total current liabilities |
|
|
||||||||||||
Long-term borrowings |
|
|
||||||||||||
Accrued pensions |
|
|
||||||||||||
Deferred income taxes |
|
|
||||||||||||
Other liabilities |
|
|
||||||||||||
Total liabilities |
|
|
||||||||||||
Commitments and contingent liabilities (Note 5) |
|
|
||||||||||||
Shareholders’ equity: | ||||||||||||||
Common shares, $
|
|
|
||||||||||||
Capital in excess of par |
|
|
||||||||||||
Retained earnings |
|
|
||||||||||||
Treasury shares, at cost,
|
(
|
(
|
||||||||||||
Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
Total Axalta shareholders’ equity |
|
|
||||||||||||
Noncontrolling interests |
|
|
||||||||||||
Total shareholders’ equity |
|
|
||||||||||||
Total liabilities and shareholders’ equity | $ |
|
$ |
|
Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||
Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— | — |
(
|
|
|||||||||||||||||||||||||||||||||||||||
Long-term employee benefit plans, net of tax of $
|
— | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
Total comprehensive income (loss) | — | — | — |
|
— |
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Shares issued under compensation plans |
|
— |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Balance at March 31, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Common Stock | |||||||||||||||||||||||||||||||||||||||||||||||
Number of Shares | Par/Stated Value | Capital In Excess Of Par | Retained Earnings | Treasury Shares, at cost | Accumulated Other Comprehensive Loss | Non controlling Interests | Total | ||||||||||||||||||||||||||||||||||||||||
Balance at December 31, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Comprehensive income: | |||||||||||||||||||||||||||||||||||||||||||||||
Net income | — | — | — |
|
— | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Net realized and unrealized loss on derivatives, net of tax of $
|
— | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation, net of tax of $
|
— | — | — | — | — |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
Total comprehensive income | — | — | — |
|
— |
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
Recognition of stock-based compensation | — | — |
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Shares issued under compensation plans |
|
|
|
— | — | — | — |
|
|||||||||||||||||||||||||||||||||||||||
Balance at March 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||
Three Months Ended
March 31, |
||||||||||||||
2024 | 2023 | |||||||||||||
Operating activities: | ||||||||||||||
Net income | $ |
|
$ |
|
||||||||||
Adjustment to reconcile net income to cash provided by (used for) operating activities: | ||||||||||||||
Depreciation and amortization |
|
|
||||||||||||
Amortization of deferred financing costs and original issue discount |
|
|
||||||||||||
Debt extinguishment and refinancing-related costs |
|
|
||||||||||||
Deferred income taxes |
|
|
||||||||||||
Realized and unrealized foreign exchange losses, net |
|
|
||||||||||||
Stock-based compensation |
|
|
||||||||||||
Impairment charges |
|
|
||||||||||||
Interest income on swaps designated as net investment hedges |
(
|
(
|
||||||||||||
Other non-cash, net |
|
|
||||||||||||
Changes in operating assets and liabilities: | ||||||||||||||
Trade accounts and notes receivable |
|
(
|
||||||||||||
Inventories |
(
|
|
||||||||||||
Prepaid expenses and other assets |
(
|
(
|
||||||||||||
Accounts payable |
|
(
|
||||||||||||
Other accrued liabilities |
(
|
(
|
||||||||||||
Other liabilities |
|
(
|
||||||||||||
Cash provided by (used for) operating activities |
|
(
|
||||||||||||
Investing activities: | ||||||||||||||
Purchase of property, plant and equipment |
(
|
(
|
||||||||||||
Interest proceeds on swaps designated as net investment hedges |
|
|
||||||||||||
Settlement proceeds on swaps designated as net investment hedges |
|
|
||||||||||||
Other investing activities, net |
|
|
||||||||||||
Cash used for investing activities |
(
|
(
|
||||||||||||
Financing activities: | ||||||||||||||
Proceeds from short-term borrowings |
|
|
||||||||||||
Proceeds from long-term borrowings |
|
|
||||||||||||
Payments on short-term borrowings |
(
|
(
|
||||||||||||
Payments on long-term borrowings |
(
|
(
|
||||||||||||
Financing-related costs |
(
|
(
|
||||||||||||
Net cash flows associated with stock-based awards |
|
|
||||||||||||
Deferred acquisition-related consideration |
|
(
|
||||||||||||
Other financing activities, net |
|
|
||||||||||||
Cash used for financing activities |
(
|
(
|
||||||||||||
Decrease in cash |
(
|
(
|
||||||||||||
Effect of exchange rate changes on cash |
(
|
|
||||||||||||
Cash at beginning of period |
|
|
||||||||||||
Cash at end of period | $ |
|
$ |
|
||||||||||
Cash at end of period reconciliation: | ||||||||||||||
Cash and cash equivalents | $ |
|
$ |
|
||||||||||
Restricted cash |
|
|
||||||||||||
Cash at end of period | $ |
|
$ |
|
Note | Page | |||||||
Performance
Coatings |
Mobility
Coatings |
Total | ||||||||||||||||||
Balance at December 31, 2023 | $ |
|
$ |
|
$ |
|
||||||||||||||
Foreign currency translation |
(
|
(
|
(
|
|||||||||||||||||
Balance at March 31, 2024 | $ |
|
$ |
|
$ |
|
March 31, 2024 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted average
amortization periods (years) |
||||||||||||||||||||||
Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
Total | $ |
|
$ |
(
|
$ |
|
December 31, 2023 |
Gross Carrying
Amount |
Accumulated
Amortization |
Net Book
Value |
Weighted average
amortization periods (years) |
||||||||||||||||||||||
Technology | $ |
|
$ |
(
|
$ |
|
|
|||||||||||||||||||
Trademarks—indefinite-lived |
|
— |
|
Indefinite | ||||||||||||||||||||||
Trademarks—definite-lived |
|
(
|
|
|
||||||||||||||||||||||
Customer relationships |
|
(
|
|
|
||||||||||||||||||||||
Total | $ |
|
$ |
(
|
$ |
|
Remainder of 2024 | $ |
|
||||||
2025 |
|
|||||||
2026 |
|
|||||||
2027 |
|
|||||||
2028 |
|
|||||||
2029 |
|
2024 Activity | ||||||||
Balance at December 31, 2023 | $ |
|
||||||
Expenses, net of changes to estimates |
|
|||||||
Payments made |
(
|
|||||||
Foreign currency translation |
(
|
|||||||
Balance at March 31, 2024 | $ |
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Components of net periodic benefit cost:
|
||||||||||||||||||||||||||
Net periodic benefit cost: | ||||||||||||||||||||||||||
Service cost | $ |
|
$ |
|
||||||||||||||||||||||
Interest cost |
|
|
||||||||||||||||||||||||
Expected return on plan assets |
(
|
(
|
||||||||||||||||||||||||
Amortization of actuarial loss, net |
|
|
||||||||||||||||||||||||
Net periodic benefit cost | $ |
|
$ |
|
Stock Options |
Awards
(in millions) |
Weighted
Average Exercise Price |
Aggregate
Intrinsic Value (in millions) |
Weighted
Average Remaining Contractual Life (years) |
||||||||||||||||||||||
Outstanding at January 1, 2024 |
|
$ |
|
|||||||||||||||||||||||
Granted |
|
$ |
|
|||||||||||||||||||||||
Exercised |
(
|
$ |
|
|||||||||||||||||||||||
Forfeited / Expired
(1)
|
|
$ |
|
|||||||||||||||||||||||
Outstanding at March 31, 2024
|
|
$ |
|
|||||||||||||||||||||||
Vested and expected to vest at March 31, 2024
|
|
$ |
|
$ |
|
|
||||||||||||||||||||
Exercisable at March 31, 2024
|
|
$ |
|
$ |
|
|
Restricted Stock Units |
Units
(in millions) |
Weighted Average
Fair Value |
||||||||||||
Outstanding at January 1, 2024 |
|
$ |
|
|||||||||||
Granted |
|
$ |
|
|||||||||||
Vested |
(
|
$ |
|
|||||||||||
Forfeited |
(
|
$ |
|
|||||||||||
Outstanding at March 31, 2024 |
|
$ |
|
Performance Share Units |
Units
(in millions) |
Weighted Average
Fair Value |
||||||||||||
Outstanding at January 1, 2024 |
|
$ |
|
|||||||||||
Granted |
|
$ |
|
|||||||||||
Vested
(1)
|
|
$ |
|
|||||||||||
Forfeited |
(
|
$ |
|
|||||||||||
Outstanding at March 31, 2024 |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Foreign exchange losses, net | $ |
|
$ |
|
||||||||||||||||||||||
Debt extinguishment and refinancing-related costs
(1)
|
|
|
||||||||||||||||||||||||
Other miscellaneous income, net |
|
(
|
||||||||||||||||||||||||
Total | $ |
|
$ |
|
Three Months Ended
March 31, |
||||||||||||||
2024 | 2023 | |||||||||||||
Effective Tax Rate |
|
% |
|
% |
Three Months Ended
March 31, |
||||||||||||||||||||||||||
(In millions, except per share data) | 2024 | 2023 | ||||||||||||||||||||||||
Net income to common shareholders | $ |
|
$ |
|
||||||||||||||||||||||
Basic weighted average shares outstanding |
|
|
||||||||||||||||||||||||
Diluted weighted average shares outstanding |
|
|
||||||||||||||||||||||||
Net income per common share
(1)
:
|
||||||||||||||||||||||||||
Basic net income per share | $ |
|
$ |
|
||||||||||||||||||||||
Diluted net income per share | $ |
|
$ |
|
March 31, 2024 | December 31, 2023 | |||||||||||||
Accounts receivable - trade, net
(1)
|
$ |
|
$ |
|
||||||||||
Notes receivable |
|
|
||||||||||||
Other
(2)
|
|
|
||||||||||||
Total | $ |
|
$ |
|
March 31, 2024 | December 31, 2023 | |||||||||||||
Finished products | $ |
|
$ |
|
||||||||||
Semi-finished products |
|
|
||||||||||||
Raw materials |
|
|
||||||||||||
Stores and supplies |
|
|
||||||||||||
Total | $ |
|
$ |
|
March 31, 2024 | December 31, 2023 | |||||||||||||
Property, plant and equipment | $ |
|
$ |
|
||||||||||
Accumulated depreciation |
(
|
(
|
||||||||||||
Property, plant and equipment, net | $ |
|
$ |
|
March 31, 2024 | December 31, 2023 | |||||||||||||
2029 Dollar Term Loans | $ |
|
$ |
|
||||||||||
2027 Dollar Senior Notes |
|
|
||||||||||||
2029 Dollar Senior Notes |
|
|
||||||||||||
2031 Dollar Senior Notes |
|
|
||||||||||||
Short-term and other borrowings |
|
|
||||||||||||
Unamortized original issue discount |
(
|
(
|
||||||||||||
Unamortized deferred financing costs |
(
|
(
|
||||||||||||
Total borrowings, net |
|
|
||||||||||||
Less: | ||||||||||||||
Short-term borrowings |
|
|
||||||||||||
Current portion of long-term borrowings |
|
|
||||||||||||
Long-term debt | $ |
|
$ |
|
Remainder of 2024 | $ |
|
||||||
2025 |
|
|||||||
2026 |
|
|||||||
2027 |
|
|||||||
2028 |
|
|||||||
Thereafter |
|
|||||||
Total borrowings |
|
|||||||
Unamortized original issue discount |
(
|
|||||||
Unamortized deferred financing costs |
(
|
|||||||
Total borrowings, net | $ |
|
March 31, 2024 | December 31, 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||||||||||||||||||||
Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Prepaid expenses and other current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Cross-currency swaps
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
Other assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Investments in equity securities
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Other accrued liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Cross-currency swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Contingent consideration |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Other liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
Cross-currency swaps
(1)
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Long-term borrowings: | ||||||||||||||||||||||||||||||||||||||||||||||||||
2029 Dollar Term Loans |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
2027 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
2029 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
2031 Dollar Senior Notes |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Fair Value Using Significant Unobservable Inputs
(Level 3) |
||||||||
Beginning balance at December 31, 2023
|
$ |
|
||||||
Change in fair value |
|
|||||||
Foreign currency translation |
|
|||||||
Ending balance at March 31, 2024
|
$ |
|
||||||
Three Months Ended
March 31, |
||||||||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||||||||
Derivatives in Cash Flow and Net Investment Hedges | Location of (Gain) Loss Recognized in Income on Derivatives | Net Amount of Gain Recognized in OCI on Derivatives | Amount of Gain Recognized in Income | Net Amount of (Gain) Loss Recognized in OCI on Derivatives | Amount of Gain Recognized in Income | |||||||||||||||||||||||||||
Interest rate swaps | Interest expense, net | $ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
Cross-currency swaps
|
Interest expense, net |
(
|
(
|
|
(
|
Derivatives Not Designated as Hedging
Instruments under ASC 815 |
Location of (Gain) Loss Recognized in Income on Derivatives |
Three Months Ended
March 31, |
||||||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||||||||
Foreign currency forward contracts | Other expense, net | $ |
(
|
$ |
(
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Net sales
(1)
:
|
||||||||||||||||||||||||||
Refinish | $ |
|
$ |
|
||||||||||||||||||||||
Industrial |
|
|
||||||||||||||||||||||||
Total Net sales Performance Coatings |
|
|
||||||||||||||||||||||||
Light Vehicle |
|
|
||||||||||||||||||||||||
Commercial Vehicle |
|
|
||||||||||||||||||||||||
Total Net sales Mobility Coatings |
|
|
||||||||||||||||||||||||
Total Net sales | $ |
|
$ |
|
||||||||||||||||||||||
Three Months Ended
March 31, |
||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Segment Adjusted EBITDA
(1)
:
|
||||||||||||||||||||||||||
Performance Coatings | $ |
|
$ |
|
||||||||||||||||||||||
Mobility Coatings |
|
|
||||||||||||||||||||||||
Total |
|
|
||||||||||||||||||||||||
Interest expense, net |
|
|
||||||||||||||||||||||||
Depreciation and amortization |
|
|
||||||||||||||||||||||||
Debt extinguishment and refinancing-related costs
(a)
|
|
|
||||||||||||||||||||||||
Termination benefits and other employee-related costs
(b)
|
|
|
||||||||||||||||||||||||
Acquisition and divestiture-related costs
(c)
|
|
|
||||||||||||||||||||||||
Impairment charges
(d)
|
|
|
||||||||||||||||||||||||
Foreign exchange remeasurement losses
(e)
|
|
|
||||||||||||||||||||||||
Long-term employee benefit plan adjustments
(f)
|
|
|
||||||||||||||||||||||||
Stock-based compensation
(g)
|
|
|
||||||||||||||||||||||||
Environmental charge
(h)
|
|
|
||||||||||||||||||||||||
Other adjustments
(i)
|
|
(
|
||||||||||||||||||||||||
Income before income taxes | $ |
|
$ |
|
(1) | The primary measure of segment operating performance is Adjusted EBITDA, which is defined as net income before interest, taxes, depreciation, amortization and select other items impacting operating results. These other items impacting operating results are items that management has concluded are (1) non-cash items included within net income, (2) items the Company does not believe are indicative of ongoing operating performance or (3) non-recurring, unusual or infrequent items that have not occurred within the last two years or we believe are not reasonably likely to recur within the next two years. Adjusted EBITDA is a key metric that is used by management to evaluate business performance in comparison to budgets, forecasts and prior year financial results, providing a measure that management believes reflects the Company's core operating performance, which represents Adjusted EBITDA adjusted for the select items referred to above. | ||||
(a) | Represents expenses and associated changes to estimates related to the prepayment, restructuring, and refinancing of our indebtedness, which are not considered indicative of our ongoing operating performance. | ||||
(b) | Represents expenses and associated changes to estimates related to employee termination benefits, consulting, legal and other employee-related costs associated with restructuring programs and other employee-related costs. These amounts are not considered indicative of our ongoing operating performance. | ||||
(c) | Represents acquisition and divestiture-related expenses and integration activities associated with our business combinations, all of which are not considered indicative of our ongoing operating performance. | ||||
(d) | Represents impairment charges, which are not considered indicative of our ongoing operating performance. The amount recorded during the three months ended March 31, 2023 relates to a loss recorded due to the then anticipated exit of a non-core business category in the Mobility Coatings segment. | ||||
(e) | Represents foreign exchange losses resulting from the remeasurement of assets and liabilities denominated in foreign currencies, net of the impacts of our foreign currency instruments used to hedge our balance sheet exposures. | ||||
(f) | Represents the non-cash, non-service cost components of long-term employee benefit costs. | ||||
(g) | Represents non-cash impacts associated with stock-based compensation. | ||||
(h) | Represents costs related to certain environmental remediation activities, which are not considered indicative of our ongoing operating performance. | ||||
(i) | Represents costs for certain non-operational or non-cash gains, unrelated to our core business and which we do not consider indicative of our ongoing operating performance. | ||||
Unrealized
Currency Translation Adjustments |
Pension
Adjustments |
Unrealized
Gain (Loss) on Derivatives |
Accumulated
Other Comprehensive (Loss) Income |
|||||||||||||||||||||||
Balance, December 31, 2023
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Current year deferrals to AOCI |
(
|
|
|
(
|
||||||||||||||||||||||
Reclassifications from AOCI to Net income |
(
|
|
|
(
|
||||||||||||||||||||||
Net Change |
(
|
|
|
(
|
||||||||||||||||||||||
Balance, March 31, 2024
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Unrealized
Currency Translation Adjustments |
Pension
Adjustments |
Unrealized
(Loss) Gain on Derivatives |
Accumulated
Other Comprehensive (Loss) Income |
|||||||||||||||||||||||
Balance, December 31, 2022
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
Current year deferrals to AOCI |
|
|
|
|
||||||||||||||||||||||
Reclassifications from AOCI to Net income |
(
|
|
(
|
(
|
||||||||||||||||||||||
Net Change |
|
|
(
|
|
||||||||||||||||||||||
Balance, March 31, 2023
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||
(In millions) |
Three Months Ended
March 31, |
2024 vs 2023 | ||||||||||||||||||||||||||||||||||||
2024 | 2023 | % change | ||||||||||||||||||||||||||||||||||||
Performance Coatings | ||||||||||||||||||||||||||||||||||||||
Refinish | $ | 519 | $ | 498 | 4.4 | % | ||||||||||||||||||||||||||||||||
Industrial | 329 | 349 | (5.8) | % | ||||||||||||||||||||||||||||||||||
Total Net sales Performance Coatings | 848 | 847 | 0.2 | % | ||||||||||||||||||||||||||||||||||
Mobility Coatings | ||||||||||||||||||||||||||||||||||||||
Light Vehicle | 342 | 329 | 4.1 | % | ||||||||||||||||||||||||||||||||||
Commercial Vehicle | 104 | 108 | (4.3) | % | ||||||||||||||||||||||||||||||||||
Total Net sales Mobility Coatings | 446 | 437 | 2.0 | % | ||||||||||||||||||||||||||||||||||
Total Net sales | $ | 1,294 | $ | 1,284 | 0.8 | % |
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Net sales
|
$ | 1,294 | $ | 1,284 | $ | 10 | 0.8 | % | ||||||||||||||||||||||||||||||||||||||||||
Exchange rate effect | 0.7 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Price/Mix effect | 0.4 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Volume effect
|
(0.3) | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Net sales increased primarily due to the following:
|
||
n
Favorable impacts of currency translation due primarily to the fluctuations of the Mexican Peso, Euro, Brazilian Real and British Pound, partially offset by the Chinese Yuan, compared to the U.S. Dollar
|
||
n
Higher average selling prices and product mix driven by Performance Coatings
|
||
n
Decreased amortization related to BIPs of $2 million
|
||
Partially offset by:
|
||
n
Lower sales volumes within Performance Coatings, partially offset by higher sales volumes in Mobility Coatings
|
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Cost of sales | $ | 865 | $ | 902 | $ | (37) | (4.1) | % | ||||||||||||||||||||||||||||||||||||||||||
% of net sales | 66.8 | % | 70.2 | % |
Cost of sales decreased primarily due to the following:
|
||
n
Lower variable input costs as a result of deflationary benefits
|
||
n
Lower sales volumes within Performance Coatings, partially offset by higher sales volumes in Mobility Coatings
|
||
n
Decreased expense of $1 million associated with utilization at certain manufacturing sites
|
||
Partially offset by:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Increase of $1 million in inventory charges related to obsolescence, quality and yield loss in manufacturing
|
||
n
Unfavorable impacts of currency translation of 0.7% due primarily to the fluctuations of the Mexican Peso, Euro, Brazilian Real and British Pound, partially offset by the Chinese Yuan, compared to the U.S. Dollar
|
||
Cost of sales as a percentage of net sales decreased primarily due to the following:
|
||
n
Lower variable input costs as a result of deflationary benefits
|
||
n
Higher average selling prices and product mix driven by Performance Coatings
|
||
n
Decreased expense associated with utilization at certain manufacturing sites
|
||
Partially offset by:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Increase of $1 million in inventory charges related to obsolescence, quality and yield loss in manufacturing
|
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
SG&A | $ | 207 | $ | 206 | $ | 1 | 0.5 | % |
Selling, general and administrative expenses remained consistent primarily due to the following:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Unfavorable impacts of currency translation of 0.5% due primarily to the fluctuations of the Euro and Mexican Peso, partially offset by the Chinese Yuan, compared to the U.S. Dollar
|
||
Offset by:
|
||
n
Decrease of $5 million in commissions resulting from changes to contractual arrangements
|
||
n
Decrease of $3 million in bad debt expense
|
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Other operating charges | $ | 61 | $ | 7 | $ | 54 | 771.4 | % | ||||||||||||||||||||||||||||||||||||||||||
Other operating charges increased primarily due to the following:
|
||
n
Increase of $55 million in termination benefits and other employee-related costs associated with the 2024 Transformation Initiative
|
||
n
$4 million in environmental remediation costs recognized in the current year period
|
||
n
Increase of $1 million in acquisition-related costs in the current year period
|
||
Partially offset by:
|
||
n
$7 million impairment charge recognized in the prior year period related to the then anticipated exit of a non-core business category in the Mobility Coatings segment
|
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Research and development expenses
|
$ | 18 | $ | 19 | $ | (1) | (5.3) | % |
Research and development expenses remained generally consistent:
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Amortization of acquired intangibles
|
$ | 22 | $ | 25 | $ | (3) | (12.0) | % |
Amortization of acquired intangibles decreased primarily due to the following:
|
||
n
Reduced amortization of $4 million from intangibles reaching the end of their useful lives, primarily relating to intangibles from the 2013 DuPont Performance Coatings acquisition
|
||
Partially offset by:
|
||
n
Increased amortization of $1 million associated with assets acquired in the prior year
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Interest expense, net | $ | 54 | $ | 48 | $ | 6 | 12.5 | % | ||||||||||||||||||||||||||||||||||||||||||
Interest expense, net increased primarily due to the following:
|
||
•
Unfavorable impact of $9 million attributable to our 2031 Dollar Senior Notes which were issued in November 2023
|
||
n
Decreased benefit of $3 million from derivative instruments used to hedge the variable interest rate exposure on certain debt arrangements
|
||
Partially offset by:
|
||
•
Favorable impact of $5 million attributable to the redemption of our Euro-denominated Senior Notes previously due in 2025 in November 2023
|
||
n
Favorable impact of $2 million attributable to lower principal on our 2029 Dollar Term Loans, primarily as a result of $200 million of prepayments during the twelve months ended March 31, 2024, partially offset by the increased variable interest rate
|
||
n
Impacts of currency translation were immaterial when compared to the prior year period
|
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Other expense, net | $ | 8 | $ | 1 | $ | 7 | 700.0 | % |
Other expense, net increased due to the following:
|
||
n
Unfavorable impact of foreign exchange losses of $3 million when compared with the prior year period, primarily driven by fluctuations of the Euro compared to the U.S. Dollar
|
||
n
Increased debt extinguishment and refinancing-related costs of $1 million primarily driven by the repricing of our 2029 Dollar Term Loans in March 2024 and write-offs related to $75 million of prepayments on our 2029 Dollar Term Loans
|
||
n
Decreased miscellaneous income, net of $3 million
|
Three Months Ended
March 31, |
||||||||||||||||||||||||||
2024 | 2023 | |||||||||||||||||||||||||
Income before income taxes | $ | 59 | $ | 76 | ||||||||||||||||||||||
Provision for income taxes | 20 | 15 | ||||||||||||||||||||||||
Statutory U.S. Federal income tax rate
|
21.0 | % | 21.0 | % | ||||||||||||||||||||||
Effective tax rate
|
33.9 | % | 20.2 | % | ||||||||||||||||||||||
Effective tax rate vs. statutory U.S. Federal income tax rate | 12.9 | % | (0.8) | % |
(Favorable) Unfavorable Impact | ||||||||||||||||||||||||||
Three Months Ended
March 31, |
||||||||||||||||||||||||||
Items impacting the effective tax rate vs. statutory U.S. federal income tax rate
|
2024 | 2023 | ||||||||||||||||||||||||
Earnings generated in jurisdictions where the statutory rate is different from the U.S. Federal rate
(1)
|
$ | (6) | $ | (7) | ||||||||||||||||||||||
Changes in valuation allowance
(2)
|
16 | 8 | ||||||||||||||||||||||||
Foreign exchange losses (gains), net | (6) | — | ||||||||||||||||||||||||
Non-deductible expenses and interest
|
1 | 1 | ||||||||||||||||||||||||
Changes in unrecognized tax benefits | 2 | (2) |
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Net sales
|
$ | 848 | $ | 847 | $ | 1 | 0.2 | % | ||||||||||||||||||||||||||||||||||||||||||
Price/Mix effect | 1.1 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Exchange rate effect | 0.7 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Volume effect | (1.6) | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 196 | $ | 169 | $ | 27 | 16.1 | % | ||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA Margin | 23.1 | % | 20.0 | % |
Net sales increased primarily due to the following:
|
||
n
Higher average selling prices and product mix driven by the refinish end-market
|
||
n
Favorable impacts of currency translation due primarily to fluctuations of the Mexican Peso, Euro and British Pound, partially offset by the Chinese Yuan, compared to the U.S. Dollar
|
||
n
Decreased amortization related to BIPs of $1 million
|
||
Partially offset by:
|
||
n
Lower sales volumes driven by the industrial end-market due to a weaker industrial market environment and the strategic decision to exit certain low-margin categories, partially offset by increased sales volumes in the refinish end-market from the Andre Koch acquisition
|
Adjusted EBITDA and Adjusted EBITDA margin increased primarily due to the following:
|
||
n
Decreased variable input costs due to deflationary benefits
|
||
n
Higher average selling prices and product mix driven by the refinish end-market
|
||
n
Favorable impacts of currency translation due primarily to fluctuations of the Mexican Peso and Euro compared to the U.S. Dollar
|
||
Partially offset by:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Lower sales volumes driven by the industrial end-market due to a weaker industrial market environment and the strategic decision to exit certain low-margin categories, partially offset by increased sales volumes in the refinish end-market
|
Three Months Ended
March 31, |
2024 vs 2023 | |||||||||||||||||||||||||||||||||||||||||||||||||
2024 | 2023 | $ Change | % Change | |||||||||||||||||||||||||||||||||||||||||||||||
Net sales | $ | 446 | $ | 437 | $ | 9 | 2.0 | % | ||||||||||||||||||||||||||||||||||||||||||
Volume effect | 2.3 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Exchange rate effect | 0.7 | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Price/Mix effect | (1.0) | % | ||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA | $ | 63 | $ | 44 | $ | 19 | 43.9 | % | ||||||||||||||||||||||||||||||||||||||||||
Adjusted EBITDA Margin | 14.2 | % | 10.1 | % |
Net sales increased primarily due to the following:
|
||
n
Higher sales volumes driven by the light vehicle end-market, partially offset by decreased sales volumes in the commercial vehicle end-market driven by softer demand trends
|
||
n
Favorable impacts of currency translation due primarily to fluctuations of the Mexican Peso, Brazilian Real and Euro, partially offset by the Chinese Yuan, compared to the U.S. Dollar.
|
||
n
Decreased amortization related to BIPs of $1 million
|
||
Partially offset by:
|
||
n
Lower average selling prices and product mix driven by Latin America
|
Adjusted EBITDA and Adjusted EBITDA margin increased primarily due to the following:
|
||
n
Decreased variable input costs due to deflationary benefits
|
||
n
Higher sales volumes driven by the light vehicle end-market, partially offset by decreased sales volumes in the commercial vehicle end-market driven by softer demand trends
|
||
n
Decreased expense of $1 million associated with utilization at certain manufacturing sites
|
||
n
Favorable impacts of currency translation due primarily to fluctuations of the Mexican Peso compared to the U.S. Dollar
|
||
Partially offset by:
|
||
n
Higher operating expenses due primarily to increased labor costs
|
||
n
Lower average selling prices and product mix driven by Latin America
|
||
n
Increase of $1 million in inventory charges related to obsolescence, quality and yield loss in manufacturing
|
Three Months Ended
March 31, |
||||||||||||||
(In millions) | 2024 | 2023 | ||||||||||||
Net cash provided by (used for): | ||||||||||||||
Operating activities: | ||||||||||||||
Net income | $ | 39 | $ | 61 | ||||||||||
Depreciation and amortization | 68 | 70 | ||||||||||||
Amortization of deferred financing costs and original issue discount | 2 | 2 | ||||||||||||
Debt extinguishment and refinancing-related costs | 3 | 2 | ||||||||||||
Deferred income taxes | 6 | 2 | ||||||||||||
Realized and unrealized foreign exchange losses, net | 9 | 5 | ||||||||||||
Stock-based compensation | 6 | 6 | ||||||||||||
Impairment charges | — | 7 | ||||||||||||
Interest income on swaps designated as net investment hedges | (3) | (6) | ||||||||||||
Other non-cash, net | 2 | 3 | ||||||||||||
Net income adjusted for non-cash items | 132 | 152 | ||||||||||||
Changes in operating assets and liabilities | (98) | (204) | ||||||||||||
Operating activities | 34 | (52) | ||||||||||||
Investing activities | (19) | (6) | ||||||||||||
Financing activities | (82) | (88) | ||||||||||||
Effect of exchange rate changes on cash | (9) | 6 | ||||||||||||
Net decrease in cash | $ | (76) | $ | (140) |
(In millions) | March 31, 2024 | December 31, 2023 | ||||||||||||
2029 Dollar Term Loans | $ | 1,711 | $ | 1,786 | ||||||||||
2027 Dollar Senior Notes | 500 | 500 | ||||||||||||
2029 Dollar Senior Notes | 700 | 700 | ||||||||||||
2031 Dollar Senior Notes | 500 | 500 | ||||||||||||
Short-term and other borrowings | 56 | 62 | ||||||||||||
Unamortized original issue discount | (15) | (17) | ||||||||||||
Unamortized deferred financing costs | (25) | (27) | ||||||||||||
Total borrowings, net | 3,427 | 3,504 | ||||||||||||
Less: | ||||||||||||||
Short-term borrowings | 3 | 7 | ||||||||||||
Current portion of long-term borrowings | 17 | 19 | ||||||||||||
Long-term debt | $ | 3,407 | $ | 3,478 |
EXHIBIT NO.
|
DESCRIPTION OF EXHIBITS
|
|||||||
10.1* | ||||||||
10.2 | ||||||||
10.3 | ||||||||
10.4 | ||||||||
10.5 | ||||||||
31.1 | ||||||||
31.2 | ||||||||
32.1† | ||||||||
32.2† | ||||||||
101 | INS - Inline XBRL Instance Document. The document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document | |||||||
101 | SCH - Inline XBRL Taxonomy Extension Schema Document | |||||||
101 | CAL - Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||||||
101 | DEF - Inline XBRL Taxonomy Extension Definition Linkbase Document | |||||||
101 | LAB - Inline XBRL Taxonomy Extension Label Linkbase Document | |||||||
101 | PRE - Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
* |
Previously filed.
|
|||||||
^ | Denotes management contract or compensatory plan or arrangement. | |||||||
† | This certificate is being furnished solely to accompany the report pursuant to 18 U.S.C. Section 1350 and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. |
AXALTA COATING SYSTEMS LTD. | |||||||||||
Date: | May 1, 2024 | By: /s/ Chris Villavarayan | |||||||||
Chris Villavarayan | |||||||||||
Chief Executive Officer and President | |||||||||||
(Principal Executive Officer) | |||||||||||
Date: | May 1, 2024 | By: /s/ Carl D. Anderson II | |||||||||
Carl D. Anderson II | |||||||||||
Senior Vice President and Chief Financial Officer | |||||||||||
(Principal Financial Officer) | |||||||||||
Date: | May 1, 2024 | By: /s/ Anthony Massey | |||||||||
Anthony Massey | |||||||||||
Vice President and Global Controller | |||||||||||
(Principal Accounting Officer) |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
Snap-on Incorporated | SNA |
No Suppliers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|